Loading organizations...
Loading organizations...
Biotechnology company developing small molecules for undruggable targets.
BridGene Biosciences has raised $78.5M across 3 funding rounds.
BridGene Biosciences has raised $78.5M in total across 3 funding rounds.
BridGene Biosciences has raised $78.5M in total across 3 funding rounds.
BridGene Biosciences's investors include Yuexing Su, Grains Valley Venture Capital, GTJA Investment Group, Lapam Capital, Proxima Ventures, Dyee Capital, Junson Capital, Leilei Wang, Kaitai Capital, Pangu Capital, Takeda Ventures.
BridGene Biosciences has raised $78.5M across 3 funding rounds. Most recently, it raised $28.0M Series B in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 16, 2025 | $28.0M Series B | Yuexing Su | Grains Valley Venture Capital, GTJA Investment Group, Lapam Capital, Proxima Ventures |
| Jul 28, 2022 | $38.5M Series B | Dyee Capital, Junson Capital, Lapam Capital | |
| May 5, 2021 | $12.0M Series A | Leilei Wang | Kaitai Capital, Pangu Capital, Takeda Ventures |